Ionis Pharmaceuticals
在场
高管
查看带有其 23 名主要高管的组织结构图
Ionis Pharmaceuticals 搜索最多的简介
- Brett Monia, Chief Executive Officer and Director
- Joseph Loscalzo, Chairman of The Board
- Spencer Berthelsen, Director
高管在Ionis Pharmaceuticals变化
- Kyle Jenne已作为Executive Vice President and Chief Global Product Strategy Officer加入公司 (新闻发布的2024三月1号).
- Onaiza Cadoret-Manier, Executive Vice President, Chief Global Product Strategy and Operations Officer, 已经离开公司 (新闻发布的2024三月1号).
- Michael Yang已作为Director加入公司 (新闻发布的2023十二月15号).
创建提醒
跟踪 Ionis Pharmaceuticals 的高管变动
生物技术
Ionis Pharmaceuticals 拥有 2,281 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Ionis Pharmaceuticals 的最新新闻稿
- Ionis reports third quarter 2023 financial results | Ionis Pharmaceuticals, Inc.
- Ionis to present at upcoming investor conferences | Ionis Pharmaceuticals, Inc.
- Ionis to present at upcoming investor conferences | Ionis Pharmaceuticals, Inc.
- Ionis reports second quarter 2023 financial results | Ionis Pharmaceuticals, Inc.
- Ionis completes enrollment in landmark Phase 3 CARDIO-TTRansform study in patients with TTR-mediated amyloid cardiomyopathy | Ionis Pharmaceuticals, Inc.
- Ionis enters collaboration to advance next generation program targeting Lp(a) for cardiovascular disease | Ionis Pharmaceuticals, Inc.
- Ionis to hold second quarter 2023 financial results webcast | Ionis Pharmaceuticals, Inc.
- Ionis expands eplontersen agreement with AstraZeneca to include exclusive rights in Latin America | Ionis Pharmaceuticals, Inc.
- Eplontersen continued to show improvement in ATTRv-PN through 85 weeks | Ionis Pharmaceuticals, Inc.
- Ionis to present at upcoming investor conference | Ionis Pharmaceuticals, Inc.
- View more press releases Close
通过电子邮件
